Clinical Trials Logo
  1. Home
  2. Trichotillomania
  3. NCT03797521

A Study in Patients With Trichotillomania — TTM  

Trichotillomania Clinical Trial

Official title:
A Phase 2, Double Blind, Placebo-Controlled Study to Explore the Safety, Tolerability, and Activity of SXC-2023 in Adults With Moderate to Severe Trichotillomania (TTM) When Dosed for 6 Weeks

Clinical Trial Summary

The purpose of this study is to explore the safety, tolerability and activity of SXC-2023 when dosed for 6 weeks versus placebo in adult patients with moderate to severe Trichotillomania.

Clinical Trial Description

This is a Phase 2, multicenter, double-blind, placebo-controlled, parallel-group study consisting of a screening period of up to 40 days, a 6 week randomized double-blind treatment period, followed by an up to 2 week safety follow-up period after the last dose of study medication. Patients will be randomized to one of four treatment groups. Patients will participate for a total of up to 10 weeks, including screening, the 6-week treatment period and follow-up. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03797521
Study type Interventional
Source Promentis Pharmaceuticals, Inc.
Contact
Status Completed
Phase Phase 2
Start date December 19, 2018
Completion date December 16, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT01445444 - Habit Reversal Training for Children and Adolescents With Trichotillomania N/A
Completed NCT04559750 - Internet CBT for Trichotillomania and Skin Picking Disorder N/A
Completed NCT01638975 - Response Inhibition Training for Individuals With Trichotillomania N/A
Completed NCT00993265 - N-Acetylcysteine for Pediatric Trichotillomania Phase 2
Completed NCT00917098 - Examining Behavior Therapy for Trichotillomania in Children and Adolescents N/A
Recruiting NCT00552266 - Methylphenidate in ADHD With Trichotillomania Phase 4
Completed NCT03530800 - Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors Phase 2/Phase 3
Completed NCT01984333 - Online Response Inhibition Training for Trichotillomania N/A
Completed NCT00740909 - Cognitive Behavioral Therapy for Trichotillomania Phase 1/Phase 2
Recruiting NCT05003401 - Leveraging Technological Advancements to Improve the Treatment of Trichotillomania N/A
Completed NCT01875445 - Inositol in Trichotillomania Phase 2
Completed NCT03486041 - Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania N/A
Completed NCT02473913 - Milk Thistle in Trichotillomania in Children and Adults Phase 2
Completed NCT00872742 - Testing a New Therapy for Trichotillomania Phase 2
Completed NCT00182507 - Olanzapine in the Treatment of Hair Pulling (Trichotillomania) Phase 4
Completed NCT00947154 - Trial of Aripiprazole in Trichotillomania N/A
Completed NCT00354770 - N-Acetyl Cysteine in Trichotillomania Phase 2
Completed NCT00004550 - Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions N/A
Completed NCT01878110 - Efficacy of COMB (Comprehensive Behavioral) Model of Treatment of Trichotillomania N/A
Active, not recruiting NCT01075672 - Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals N/A